PT  - JOURNAL ARTICLE
AU  - Amir A. Mufaddel
AU  - Ghanem A. Al-Hassani
TI  - Familial idiopathic basal ganglia calcification (Fahr’s disease)
DP  - 2014 Jul 01
TA  - Neurosciences Journal
PG  - 171--177
VI  - 19
IP  - 3
4099  - http://nsj.org.sa/content/19/3/171.short
4100  - http://nsj.org.sa/content/19/3/171.full
SO  - Neurosciences (Riyadh)2014 Jul 01; 19
AB  - Familial idiopathic basal ganglia calcification (Fahr’s disease) is a rare neurodegenerative disorder characterized by symmetrical and bilateral calcification of the basal ganglia. Calcifications may also occur in other brain regions such as dentate nucleus, thalamus, and cerebral cortex. Both familial and non-familial cases of Fahr’s disease have been reported, predominantly with autosomal-dominant fashion. The disease has a wide range of clinical presentations, predominantly with neuropsychiatric features and movement disorders. Psychiatric features reported in the literature include: cognitive impairment, depression, hallucinations, delusions, manic symptoms, anxiety, schizophrenia-like psychosis, and personality change. Other clinical features include: Parkinsonism, ataxia, headache, seizures, vertigo, stroke-like events, orthostatic hypotension, tremor, dysarthria, and paresis. Fahr’s disease should be considered in the differential diagnosis of psychiatric symptoms, particularly when associated with movement disorder. The disease should be differentiated from other conditions that can cause intracranial calcification. No specific treatment is currently available. Further research is needed to bridge the gap existing in our current knowledge of the prevalence, etiology, symptoms, and treatment of Fahr’s disease.